Naj IM

Language: Spanish
References: 2
Page: 172-173
PDF size: 121.55 Kb.

Text Extraction

The World Health Organization (WHO) recognizes epilepsy as a serious public health concern with over 50 million people worldwide suffering from the disease. A recent report from the Centers for Disease Control and Prevention (CDC) in the United States (US) recently estimated that up to 56% of adults with epilepsy in the US have uncontrolled seizures. Epilepsy surgery has become an excellent option in children and adult patients with pharmacoresistant epilepsy. For a carefully selected subset of patients with drug-resistant focal epilepsy, surgical resection has been demonstrated to be a more effective treatment option than continued pharmacological therapy. We recently calculated an annual period prevalence of ~50 epilepsy surgical candidates in 100,000 adults and ~15 in 100,000 children and an annual incidence of ~3 epilepsy surgical candidates in 100,000 adults and ~2 in 100,000 children (López-Rivera et al, In Press).

REFERENCES

1. Tian N, Boring M, Kobau R, Zack MM, Croft JB. Active epilepsy and seizure control in adults - United States, 2013 and 2015. MMWR Morb Mortal Wkly Rep. 2018; 67 (15): 437-442.

2. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001; 345 (5): 311-318. doi: 10.1056/NEJM200108023450501.